---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-055047"
form_type: "8-K"
ticker: "ASH"
cik: "0001674862"
company_name: "ASHLAND INC."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T10:56:52.955496+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Ashland to sell nutraceuticals business to Turnspire; expects $110-120M impairment in Q3 FY2024

## Summary
- Signed definitive agreement to sell nutraceuticals business to Turnspire Capital Partners; closing expected calendar Q3 2024.
- Expects non-cash impairment charge of $110M to $120M in Q3 fiscal 2024, substantially offset by tax benefits.
- Nutraceuticals business supplies active ingredients and formulation aids from four facilities in US and Mexico.
- No purchase price disclosed in the filing.
- Citi and Cravath, Swaine & Moore are acting as financial and legal advisors to Ashland.

## SEC filing metadata
- accession: 0000950170-24-055047
- form_type: 8-K
- ticker: ASH
- cik: 0001674862
- company_name: ASHLAND INC.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.06, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674862/000095017024055047/0000950170-24-055047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674862/000095017024055047/ash-20240506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-055047
- JSON: https://secwatch.observer/filing/0000950170-24-055047.json
- Plain text: https://secwatch.observer/filing/0000950170-24-055047.txt

## Key facts
- Restructurings & Charges
  ASHLAND INC. announced a impairment with charges of $110 million to $120 million affecting nutraceuticals business.
  - Type: impairment
  - Charge: $110 million to $120 million
  - Affected area: nutraceuticals business
  source text: the Company expects to incur a non-cash impairment charge relating to the goodwill and other intangible assets and property, plant and equipment of this business during the third quarter of fiscal 2024 in the range of $110 million to $120 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1674862/000095017024055047/0000950170-24-055047-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.